Spanish researchers develop a 'promising' cream treatment for a tropical disease that affects millions of people

Spanish researchers from the 12 de Octubre Hospital Research Institute i+12 and the Complutense University of Madrid have developed a promising therapeutic strategy to combat cutaneous leishmaniasis, a neglected tropical disease that affects millions of people worldwide. The study, conducted in mice, demonstrated that immunochemotherapy - a combination of drug treatment with a vaccine - is significantly more effective than using the drug alone. This approach represents a potential advancement in the treatment of a disease that continues to have a global impact.